First Time Loading...

Theseus Pharmaceuticals Inc
NASDAQ:THRX

Watchlist Manager
Theseus Pharmaceuticals Inc Logo
Theseus Pharmaceuticals Inc
NASDAQ:THRX
Watchlist
Price: 4.06 USD Market Closed
Updated: May 12, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

234.6m
-4%
Assets
Growth Rates:
1 Year
+2%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
10.1m
-8%
Liabilities
Growth Rates:
1 Year
-14%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
224.5m
-4%
Equity
Growth Rates:
1 Year
+3%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Theseus Pharmaceuticals Inc

234.6m
Assets
10.1m
Liabilities
234.6m
Assets
10.1m
Liabilities
Current Assets 209.6m
Cash & Short-Term Investments 205.1m
Other Current Assets 4.5m
Non-Current Assets 25m
Long-Term Investments 20.3m
PP&E 4.3m
Other Non-Current Assets 400k
Current Liabilities 7m
Accounts Payable 1.3m
Accrued Liabilities 5.3m
Other Current Liabilities 400k
Non-Current Liabilities 3.1m
Other Non-Current Liabilities 3.1m

Balance Sheet
Theseus Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
1
9
245
95
Cash Equivalents
1
9
245
95
Short-Term Investments
0
0
0
103
Other Current Assets
0
0
3
4
Total Current Assets
1
9
248
202
PP&E Net
0
0
0
5
PP&E Gross
0
0
0
5
Accumulated Depreciation
0
0
0
0
Long-Term Investments
0
0
0
14
Other Long-Term Assets
0
0
3
2
Total Assets
1
N/A
9
+514%
251
+2 817%
222
-11%
Liabilities
Accounts Payable
0
1
1
5
Accrued Liabilities
0
1
2
6
Short-Term Debt
0
0
0
0
Other Current Liabilities
0
0
1
0
Total Current Liabilities
1
2
4
11
Long-Term Debt
0
0
0
0
Other Liabilities
3
0
1
4
Total Liabilities
4
N/A
2
-60%
5
+181%
15
+229%
Equity
Common Stock
7
41
0
0
Retained Earnings
10
34
62
112
Additional Paid In Capital
1
0
308
320
Other Equity
0
0
0
0
Total Equity
3
N/A
7
N/A
246
+3 420%
208
-16%
Total Liabilities & Equity
1
N/A
9
+514%
251
+2 817%
222
-11%
Shares Outstanding
Common Shares Outstanding
38
38
39
39

See Also

Summary
THRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
THRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
THRX stock valuation using valuation multiples.
Wall Street Estimates
THRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
THRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.